CN108553493A - A kind of ganoderma lucidum American Ginseng cervus elaphus linnaeus capsule formula - Google Patents
A kind of ganoderma lucidum American Ginseng cervus elaphus linnaeus capsule formula Download PDFInfo
- Publication number
- CN108553493A CN108553493A CN201810592100.6A CN201810592100A CN108553493A CN 108553493 A CN108553493 A CN 108553493A CN 201810592100 A CN201810592100 A CN 201810592100A CN 108553493 A CN108553493 A CN 108553493A
- Authority
- CN
- China
- Prior art keywords
- american ginseng
- cervus elaphus
- elaphus linnaeus
- ganoderma lucidum
- capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a kind of ganoderma lucidum American Ginseng cervus elaphus linnaeus capsule formulas to be made of following raw material by mass percentage：Cervus elaphus linnaeus powder 18 22%, American ginseng extract 23 27%, Ganodenna Lucidum P.E 28 32%, starch 22 26%, silica 1 %.The ganoderma lucidum American Ginseng cervus elaphus linnaeus capsule of the present invention uses raw material integration of drinking and medicinal herbs, ingredient mutually to cooperate with, cooperate, and is processed by traditional handicraft, drying, crushing, and effective component extracting and concentration are packed into capsule and form.Compared with the prior art, the present invention has the advantages of：The present invention has the health food of anti-aging, kidney tonifying void, tonifying primordial Qi and immunoloregulation function, function of physical fatigue alleviation.
Description
Technical field
The present invention relates to a kind of capsule more particularly to a kind of ganoderma lucidum American Ginseng cervus elaphus linnaeus capsule formulas.
Background technology
People are usually dog-tired because of Working Life now, occur being easy aging, kidney deficiency, hinder under vigour, immunity
The symptoms such as drop, traditional health products are in anti-aging, kidney tonifying is empty, tonifying primordial Qi and immunoloregulation function, function of physical fatigue alleviation etc.
The less effective of aspect cannot play good health-care effect.
Invention content
The present invention provides a kind of ganoderma lucidum American Ginseng cervus elaphus linnaeus capsule formula to solve the above-mentioned deficiency of the prior art.
The above-mentioned purpose of the present invention is realized by technical solution below：A kind of ganoderma lucidum American Ginseng cervus elaphus linnaeus capsule is matched
Side, by mass percentage, is made of following raw material：Cervus elaphus linnaeus powder 18-22%, American ginseng extract 23-27%, Ganodenna Lucidum P.E
28-32%, starch 22-26%, silica 1 %.
Preferably, the ganoderma lucidum American Ginseng cervus elaphus linnaeus capsule formula is made of following raw material by mass percentage：Red deer
Fine and soft powder 19-21%, American ginseng extract 22-26%, Ganodenna Lucidum P.E 27-31%, starch 23-25%, silica 1 %.
Preferably, the ganoderma lucidum American Ginseng cervus elaphus linnaeus capsule formula is made of following raw material by mass percentage：Red deer
Fine and soft powder 20%, American ginseng extract 25%, Ganodenna Lucidum P.E 30%, starch 24%, silica 1 %.
The ganoderma lucidum American Ginseng cervus elaphus linnaeus capsule of the present invention uses raw material integration of drinking and medicinal herbs, ingredient mutually to cooperate with, cooperate, press
Traditional handicraft processes, drying, crushing, and effective component extracting and concentration are packed into capsule and form.
Compared with the prior art, the present invention has the advantages of：The present invention has empty anti-aging, kidney tonifying, tonifying primordial Qi and immunological regulation
The health food of function, function of physical fatigue alleviation.
Specific implementation mode
The present invention is described in further detail with reference to embodiment.
Embodiment 1：A kind of ganoderma lucidum American Ginseng cervus elaphus linnaeus capsule formula is made of following raw material by mass percentage：Red deer
Fine and soft powder 18%, American ginseng extract 27%, Ganodenna Lucidum P.E 28%, starch 26%, silica 1 %.
Embodiment 2：A kind of ganoderma lucidum American Ginseng cervus elaphus linnaeus capsule formula is made of following raw material by mass percentage：Red deer
Fine and soft powder 20%, American ginseng extract 25%, Ganodenna Lucidum P.E 30%, starch 24%, silica 1 %.
Embodiment 3：A kind of ganoderma lucidum American Ginseng cervus elaphus linnaeus capsule formula is made of following raw material by mass percentage：Red deer
Fine and soft powder 22%, American ginseng extract 23%, Ganodenna Lucidum P.E 32%, starch 22%, silica 1 %.
The above specific embodiments are only exemplary, is to preferably make skilled artisans appreciate that originally
Patent, be not to be construed as include to this patent range limitation；As long as appointing according to made by spirit disclosed in this patent
How with change or modification, the range that this patent includes is each fallen within.
Claims (3)
1. a kind of ganoderma lucidum American Ginseng cervus elaphus linnaeus capsule formula, it is characterised in that：By mass percentage, it is made of following raw material：Horse
Pilose antler powder 18-22%, American ginseng extract 23-27%, Ganodenna Lucidum P.E 28-32%, starch 22-26%, silica 1 %.
2. a kind of ganoderma lucidum American Ginseng cervus elaphus linnaeus capsule formula according to claim 1, it is characterised in that：Described ganoderma lucidum the West
Ginseng cervus elaphus linnaeus capsule formula is made of following raw material by mass percentage：Cervus elaphus linnaeus powder 19-21%, American ginseng extract 22-
26%, Ganodenna Lucidum P.E 27-31%, starch 23-25%, silica 1 %.
3. a kind of ganoderma lucidum American Ginseng cervus elaphus linnaeus capsule formula according to claim 1, it is characterised in that：Described ganoderma lucidum the West
Ginseng cervus elaphus linnaeus capsule formula is made of following raw material by mass percentage：Cervus elaphus linnaeus powder 20%, American ginseng extract 25%, spirit
Sesame extract 30%, starch 24%, silica 1 %.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810592100.6A CN108553493A (en) | 2018-06-11 | 2018-06-11 | A kind of ganoderma lucidum American Ginseng cervus elaphus linnaeus capsule formula |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810592100.6A CN108553493A (en) | 2018-06-11 | 2018-06-11 | A kind of ganoderma lucidum American Ginseng cervus elaphus linnaeus capsule formula |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108553493A true CN108553493A (en) | 2018-09-21 |
Family
ID=63553322
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810592100.6A Pending CN108553493A (en) | 2018-06-11 | 2018-06-11 | A kind of ganoderma lucidum American Ginseng cervus elaphus linnaeus capsule formula |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108553493A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114209056A (en) * | 2021-12-22 | 2022-03-22 | 聂永志 | American ginseng and cervus elaphus linnaeus capsules |
-
2018
- 2018-06-11 CN CN201810592100.6A patent/CN108553493A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114209056A (en) * | 2021-12-22 | 2022-03-22 | 聂永志 | American ginseng and cervus elaphus linnaeus capsules |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1830332A (en) | Manufacturing method of health-care barley tea | |
| CN108553493A (en) | A kind of ganoderma lucidum American Ginseng cervus elaphus linnaeus capsule formula | |
| CN101225353B (en) | Acanthopanax root grape wine and process for preparing the same | |
| CN103976256B (en) | A kind of lotus leaf Antilipemic health face and preparation method thereof | |
| CN107022463A (en) | The preparation method of Dendrobidium huoshanness wine | |
| CN105795042A (en) | Olive tea and making method thereof | |
| CN104106822A (en) | Antrodia camphorata beverage and preparation technology thereof | |
| CN103976253A (en) | Radix puerariae health care noodle and preparation method thereof | |
| CN103919003B (en) | A kind of cake with anti-fatigue effect | |
| CN105558149A (en) | Manufacturing technology of lucid ganoderma white tea cake | |
| CN103445077A (en) | Green tea buckwheat fine dried noodles and preparing method thereof | |
| CN102894287A (en) | Rose scent noodle | |
| CN104304979A (en) | Lung-moistening Indian rorippa herb health noodles and preparation method thereof | |
| CN105581225A (en) | Five-element five-color food grain flour | |
| CN104489171A (en) | Lily flower tea drink formula and preparation method thereof | |
| CN107897465A (en) | It is a kind of that there is the candy of Appetizing spleen-tonifying | |
| CN103494072A (en) | Method for making kelp paste rice cake | |
| CN104186853A (en) | Hawthorn fruit tea and preparation method thereof | |
| CN102960621A (en) | Lotus root tea noodle | |
| KR20100092134A (en) | Small ball typed hot pepper sauce containing mulberry leaves powder and making process thereof | |
| CN107432419A (en) | A kind of rose peppermint Zongzi | |
| CN104186794A (en) | Medlar and jujube tea and preparation method of medlar and jujube tea | |
| CN105851305A (en) | Hangover tea | |
| CN104012864A (en) | Noodles with brain-strengthening efficacy | |
| CN105962049A (en) | Longan rice noodle |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180921 |
|
| RJ01 | Rejection of invention patent application after publication |